Abstract
Assortment composition of the medicines with antispasmodic action in the Republic of Uzbekistan was analyzed on the basis of the corresponding numbers 24, 25 and 26 of the State Register of Medicines and Medical Products for 2020, 2021, 2022. KEYWORDS: simetikon, drotaverine hydrochloride, antispasmodic, combined drug, market analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: EPRA International Journal of Economic and Business Review
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
